CureVac

Healthcare 📍 Tübingen, Germany 👥 501-1000 employees 💰 $328.0M raised 📅 Founded 2000

CureVac GmbH is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA (mRNA). CureVac's lead programme is dedicated to the development of active immunotherapies (based on its RNActiveÂ® technology) for the treatment of prostate cancer and non-small cell lun

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Germany

Employees

501-1000

Total Raised · Venture

$328.0M

Founded

2000

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$3M – $7M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from CureVac's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Peloton Interactive

1001-5000 ☁️ Vercel

1001-5000 ☁️ Unknown

1001-5000 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction